Publication of our paper “Human Brain/Cloud Interface” in Frontiers Neuroscience Ebook

The "Human Brain/Cloud Interface" paper has had more views than 99% of Frontiers articles. It has now been added to Frontier's "Nanotechnologies in Neuroscience and Neuroengineering" ebook which is available for download. Contributors: Frank J. Boehm (NanoApps Medical Inc. Founder), Nuno R. B. Martins, Amara Angelica, Yuriy Svidinenko, Ioan Opris, Mikhail A. Lebedev, Melanie [...]

By |2022-06-11T13:12:47+00:00May 4th, 2020|Categories: News|0 Comments

The scientific advances we need to stop COVID-19 by Bill Gates

This is the full-length version of this post. You can read the condensed version, which appeared as an opinion article in the Washington Post, here. The coronavirus pandemic pits all of humanity against the virus. The damage to health, wealth, and well-being has already been enormous. This is like a world war, except in this case, [...]

By |2020-05-01T20:01:15+00:00May 1st, 2020|Categories: News|0 Comments

New nanophotonic saliva/nasal swab test to instantly detect coronavirus with lasers

European photonics scientists are developing an ultrasensitive laser sensor that detects coronavirus at the earliest point of infection from a saliva or nasal swab in minutes. Responding to the European Commission’s Express Calls to tackle the coronavirus pandemic, photonics scientists are developing a new rapid, non-invasive ‘optical biosensor’ demonstrator that will detect Covid-19 in [...]

By |2020-05-01T19:27:10+00:00May 1st, 2020|Categories: News|0 Comments

Why COVID-19 may attack the body differently than we think

Understanding how COVID-19 attacks the human body is essential to developing an effective treatment or vaccine to stop the global pandemic — but there's still so much we don't know about how it can kill us. As researchers around the world race to understand the illness, they are compiling and sharing their early observations of patients hit [...]

By |2020-04-19T13:51:24+00:00April 19th, 2020|Categories: News|0 Comments

Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment

Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned. Remdesivir was one of the first medicines identified as having the potential to impact SARS-CoV-2, the novel [...]

By |2020-04-18T10:55:36+00:00April 18th, 2020|Categories: News|0 Comments

Coronavirus mutation could threaten the race to develop vaccine

A coronavirus strain isolated in India carried a mutation that could upend vaccine development around the globe, according to researchers from Australia and Taiwan. The non-peer reviewed study said the change had occurred in part of the spike protein that allows the virus to bind with certain human cells. This structure targets cells containing [...]

By |2020-04-17T14:27:59+00:00April 17th, 2020|Categories: News|0 Comments

COVID-19: Anti-parasitic drug Ivermectin eliminates SARS-CoV-2 in cells in 48 hours

Ivermectin shows promise as potential COVID-19 therapy. Summary: An FDA-approved anti-parasitic drug called Ivermectin appears to inhibit and eliminate SARS-CoV-2 in lab-grown cell cultures within 48 hours. Ivermectin shows promise as potential COVID-19 therapy. However, researchers stress the need for further testing and clinical trials in humans to confirm the effectiveness of the drug [...]

By |2020-04-09T19:40:20+00:00April 9th, 2020|Categories: News|0 Comments

Severe Covid-19 illness in young possibly down to genes or ‘viral load’, scientists say

Coronavirus hits the old and those with other health problems hardest, but fit, youthful people are dying too, and experts are trying to understand why: It remains one of the biggest puzzles of the Covid-19 pandemic. The disease generally causes serious problems only in older people or those with underlying health problems. But occasionally it strikes [...]

By |2020-04-05T11:15:04+00:00April 5th, 2020|Categories: News|0 Comments

The race to find a coronavirus treatment has one major obstacle: Big Pharma

he past few weeks have revealed the worst and the best in human responses to the coronavirus crisis – from the supermarket hoarders clearing the shelves to the neighbourhood groups organising help for elderly and vulnerable people. When it comes to the pharmaceutical companies, how should we judge their response? They, after all, hold [...]

By |2020-04-02T10:29:11+00:00April 2nd, 2020|Categories: News|0 Comments

Oxford firm to screen 15,000 drugs in search for coronavirus cure

An Oxford-based firm that uses artificial intelligence to develop new medicines has teamed up with a UK national science facility to screen more than 15,000 drugs for their effectiveness as a treatment for Covid-19. Exscientia, a spinoff company from the University of Dundee that is now based in Oxford science park, said it had [...]

By |2020-04-01T12:35:44+00:00April 1st, 2020|Categories: News|0 Comments
Go to Top